Vaxxed & Unvaxxed
Kids Not Compared
http://gaia-health.com
Conflicts of interest
are rampant in vaccine research. How and why they exist are the topic
of a journal article reviewed here. This is why research that could
prove that vaccines are safe hasn’t been done.
A new report published
in the journal, Accountability in Research, reviews and discusses all
areas of conflicts of interest in vaccination research. The author
paints a very dark picture, but it’s one that cannot be
legitimately denied. Conflicts of interest have resulted in research
that isn’t worthy of the term.
The Author
Gayle DeLong, the
author of Conflicts of Interest in Vaccine Safety Research, frankly
spells out her own conflicts. She is the mother of two children with
pervasive developmental disorders. She has filed a petition in the
U.S. Court of Federal Claims under the National Vaccine Injury
Compensation Program for one of her daughters. She is a former member
of the board of directors of Sensible Action for Ending
Mercury-Induced Neurological Disorders (SafeMinds).
She doesn’t point out
her career qualifications for the article. She holds a Ph.D. in
Finance and International Business from the Stern School of Business,
New York University. Regulated industries are an area of her
expertise. Her work has been published in the Journal of Financial
Economics, the Journal of Finance, the Journal of Toxicology and
Environmental Health, and the Journal of International Money and
Finance. She is well qualified to discuss the issue of conflict of
interest in the vaccination industry.
DeLong investigates
conflicts of interest for every imaginable entity involved in vaccine
research and safety.
Vaccine
Manufacturers
The conflict of
interest (COI) among vaccine manufacturers is fairly obvious.
Worldwide sales of pediatric vaccines alone were $11.5 billion in
2009, and it’s expected to reach $20 billion by 2014. The usual
risk of lawsuits when products go bad and cause injury doesn’t help
curb ineffective or unsafe vaccines because The National Childhood
Vaccination Injury Act of 1986 indemnifies them in the event of
injury. This waiver was given because pharmaceutical corporations
were refusing to develop new vaccines, saying that they were not
profitable.
The one arena in which
pharmaceutical manufacturers express concern about safety is the
potential loss of sales. DeLong tells the tale of Maurice Hilleman, a
vaccine researcher for Merck. In an internal memo in 1991, he
reported that some countries were considering a ban on thimerosal, a
mercury-containing preservative. He said that he didn’t know if
thimerosal is dangerous. However, he warned that public perceptions
could affect sales. The one concern Hilleman expressed had nothing to
do with investigating whether mercury was safe, but whether the
company should reduce the amount of thimerosal in vaccines because of
public perceptions.
The influence of
vaccine manufacturers is ubiquitous. They sponsor research and
researchers. A survey of the top US medical research institutions
found that over two-thirds of the researchers received industry
support. Unsurprisingly, studies have shown that researchers tend to
get results that coincide with their financial interests.
Entire institutions are
affected by pharma money. Whether it comes in the form of grants,
endowed chairs, or other goodies, the results sway entire
institutions to get on board with what pharma wants.
A more subtle form of
control is pharma giving the bulk of their university-related money
to senior and well-established researchers who played ball with them.
A clear message is sent to younger researchers that they must play
the same game.
Authors of research
papers do not always disclose all their associations with pharma
corporations, leaving the reader unaware of potentially worrisome
connections. This echoes Big Tobacco’s ability to find researchers
willing to compromise themselves by calling smoking safe.
Big Pharma’s
influence is ubiquitous in every arena where it has an interest. As a
result, most published vaccine-related research is questionable.
Food and Drug
Administration (FDA)
DeLong points out that
the FDA’s mission inherently results in conflict of interest. It
states that the first mission is to protect:
… the public health
by assuring the safety, efficacy, and security of human and
veterinary drugs. … The FDA also helps the public get the accurate,
science-based information they need to use medicines and foods to
improve their health.”
The FDA has approved
the vaccines used in the US. If the agency were to sponsor a study
that demonstrates a link between autism and vaccinations, it could,
according to DeLong, “greatly damage the Administration’s
reputation and reduce public trust in the FDA.”
The manner in which the
FDA is funded creates a major COI. The 1992 Prescription Drug User
Fee Act requires pharmaceutical companies to pay fees for evaluation
of their drugs. Although vaccines are not specifically included in
this act, the fact is that most pharmaceutical companies that make
vaccines also make drugs—and those fees for drugs certainly help
make the FDA friendly towards them.
Parents of vaccine
injured children can file claims in the Division of Vaccine Injury
Compensation (DVIC), which is a division of the Department of Health
and Human Services (HHS). The FDA is also a division of HHS. If the
FDA provided information that could support DVIC claims, it could
also be used against the FDA.
This is an arena where
we can be sure that a significant COI exists. DeLong states:
As of December 2011,
over 5,600 autism claims have been filed in DVIC. The average payout
for vaccine-related injuries is close to $825,000 (DHHS,2011), so the
autism claims could cost the Program over $4.6 billion. Additionally,
more parents would seek compensation if DVIC recognized autism as a
vaccine injury.
If we consider how many
children are now found to have autism—with the CDC now estimating 1
in 88—it seems obvious that DeLong’s estimate of DVIC being at
risk to the tune of $4.6 billion is extremely low. The number of
children in the US is now about 89 million. That’s well over a
million children with autism. Over $825 billion dollars could be due
these families! That’s nearly a trillion dollars—and it doesn’t
include all the children with other conditions that are likely
related to vaccines. Once the flood doors open on autism, they’d
remain open. This is a nation-busting issue—and that’s one
stunning conflict of interest!
In my view, this is the
most significant conflict of interest. To admit that vaccines cause
autism and other severe disabilities would put the government in an
unsustainable position, both morally and financially. Thus, no
admission of such a connection will be made.
Centers for Disease
Control (CDC)
Graphic by Jonik
Editorial Cartoons (altered by modifications to reference
vaccine-associated agencies).
The CDC’s conflict of
interest is inherent in the mandates that it’s charged with. The
agency is charged with preventing and controlling disease, injury,
and disability. The primary method by which they attempt to control
disease is through promoting vaccination. Upon FDA approval, they set
the recommended vaccination schedule. But they’re also charged with
doing research on vaccine safety.
So, if the CDC promotes
vaccinations without first assuring their safety, how can they also
control disabilities caused by vaccines? Obviously, there’s a
conflict of interest. To admit that its own policy of vaccination is
the cause of autism would mean that the CDC doesn’t actually
support its goal of preventing disability, that it’s actually
causing it. Therefore, it’s no surprise the the CDC is not inclined
to support genuine research into vaccine safety.
Officials at the CDC
are noted for using their term at the agency as a stepping stone to
extremely high-paying positions with the pharmaceutical industry.
Julie Geberding was the CDC’s Director from 2002 to 2008. During
her tenure, she promoted vaccination heavily. As soon as the one-year
time span for taking a position with Big Pharma had elapsed, she
became president of Merck Vaccines. The use of the CDC as a career
path to bigger and better things within the industry that’s
supposedly being regulated is an obvious conflict of interest.
Institute of
Medicine (IOM)
The IOM is, presumably,
an independent nonprofit agency. However, it does take grants from
the CDC. Therefore, when it was tasked by the CDC to do a study on
whether there might be a connection between vaccines containing
thimerosal and autism, they knew on which side their bread is
buttered.
Dr. Marie McCormick,
who was Chair of the IOM’s Immunization Safety Review Committee,
stated of the proposed study:
We are not ever going
to come downthat [autism] is a true side effect [of vaccines].
As DeLong points out,
she was declaring their conclusion before even performing the study!
In their final report,
The IOM evaded the issue. They said that, though a link between
autism and vaccines was “theoretically possible”, no causal link
had been found in epidemiological studies. Therefore, they suggested
that it would be better to channel funds for such a study to “more
promising areas of research”.
Notice that they made a
statement that is, on its face, absurd. Causation is not found
through epidemiological studies! Associations are, but
causation—though there may seem to be an obvious cause-and-effect
connection—is not formally ascertained through such a study. This
merely highlights that the IOM clearly wanted to be clear of doing
that study about vaccine safety. If they found a connection to
autism, then they’d risk losing grants.
Congress
Members of congress
receive significant contributions from pharmaceutical and health
products industries. These contributions have been growing at an
enormous rate. Members of congress are fully aware that they must
capitulate to their financers if they’ve any hope of being
reelected. But that’s probably even less important than that many
members of congress go on to very lucrative positions as lobbyists
with these same pharma corporations. Since most of them don’t spend
their lives representing the folk back home, instead moving on to
other things that result from their congressional tenure, they aren’t
likely to bite the hands that feed their nice lifestyles.
It should come as no
surprise that members of congress are shy about doing anything
critical of the pharmaceutical industry. Should they attempt to
mandate a study that might have a negative impact on the profits of
Big Pharma, they aren’t going to get the donations needed to get
re-elected, nor are they going to receive lucrative offers after
leaving.
Medical Journals
DeLong states:
Medical journal
authors’ ties to vaccine manufacturers are pervasive, as revealed
in a review of authors of vaccine safety articles published in top
journals. …
… Not only authors,
but also journals themselves can be conflicted. Washington (2011)
details thereliance of medical journals on advertising from
pharmaceutical companies, which can account for up to 99% of a
journal’s advertising revenue.
She quotes Fiona
Godlee, editor-in-chief of the BMJ:
Even on the
peer-reviewed side of things, it has been said that the journals are
the marketing arm of the pharmaceutical industry. That is not untrue.
To a large extent, that is true.
Basically, medical
journals are one big conflict of interest.
Vaccine Adverse
Events Reporting System (VAERS)
VAERS is the US’s
system for reporting adverse events resulting from vaccines. By its
nature, it’s not entirely reliable. However, it most likely
reflects a small proportion of the adverse events that afflict people
after vaccinations. One would expect that there would be a purpose
for collecting all this data.
As must be painfully
obvious at this point, vaccines are not adequately studied,
especially in terms of safety. As DeLong states:
No research sponsor has
supported a large-scale study of the prevalence of autism among
vaccinated versus unvaccinated children, nor are vaccination records
included in prospective studies.
The subject is
studiously avoided. As DeLong points out, the Columbia Center for
Children’s Environmental Health sponsors studies on prenatal and
postnatal environmental toxic exposures to search for possible
adverse effects on health. They investigate all sorts of things, but
vaccines are never on the list. Another such study, the National
Child Study, investigates environmental factors in children’s
health, but they don’t consider vaccines, either.
And no large studies
have been launched to utilize VAERS data—with the exception of a
few intrepid souls, like Michael Belkin, who take it on themselves.
It shouldn’t be surprising, though. Conflicts of interest related
to vaccination are pervasive. The easiest way to avoid finding
something that you don’t want to find is not to look for it—and
that brings us to the elephant in the vaccine room.
The Vaccine
Elephant—The Study’s Implication
Those of us who read
studies on vaccines are often stunned at the poor quality and their
apparently intentionally misleading nature. The reason for it becomes
apparent once we’re aware of the pervasiveness of conflicts of
interest. What’s amazing is that some good information comes out,
anyway.
Still, most of what’s
investigated is things like titers, the level of antibodies that
result from vaccines, with associated assumptions about whether
they’re adequate—but without any demonstration of why those
particular figures were chosen or if, indeed, they actually do
represent immunity. When it comes to safety, studies are done in
exceptionally dishonest ways. Two favorites are to do only short-term
investigations or to make comparisons utilizing active placebos. That
is, the placebos contain many of the same substances that are
believed—even known—to cause adverse reactions.
Still, as bad as these
studies are, they’re done and trotted out as evidence for both
efficacy and safety of vaccines. However, one kind of study is never
done. No large-scale comparison between vaccinated and unvaccinated
children is ever done.
Considering how
blatantly vaccine research is gamed, there can only be one reason for
this lack: The distinction between the two groups is so dramatic that
all of the techniques used to twist results cannot hide the reality.
The vaccine elephant is the comparison between the two groups. Such a
study would not be difficult to put together. There are groups of
people who are almost all unvaccinated: the Amish, the thousands of
children who’ve attended Dr. Eisenstein’s Homefirst Clinic, and a
large group of children spread out in several countries who have
attended Waldorf schools.
The elephant in the
vaccine research room is the comparison of health between vaxxed and
unvaxxed people. That research simply isn’t being done, in spite of
being the obvious way to determine whether vaccines are safe or lead
to better health.
There’s one near-sure
way to avoid finding something, and that’s not to look for it.
The lack of research
that could end the question of whether vaccines are safe simply isn’t
being done. The reason is obvious: Those who could do it won’t
because it would conflict with their careers and financial status.